JIANGSU SIMCERE PHARMACEUTICAL R & D CO LTD has a total of 11 patent applications. Its first patent ever was published in 2007. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ZENTARIS AG, SAPPHIRE THERAPEUTICS INC and ABBVIE DEUTSCHLAND.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Canada | 1 | |
#4 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Yin Xiaojin | 5 |
#2 | He Jian | 3 |
#3 | Jiang Zheng | 3 |
#4 | Zhang Anyuan | 3 |
#5 | Yang Shibao | 3 |
#6 | Li Xiaoqiang | 3 |
#7 | Huang Xin | 3 |
#8 | Tang Feng | 2 |
#9 | Jin Qiu | 2 |
#10 | Cong Xin | 2 |
Publication | Filing date | Title |
---|---|---|
WO2013033981A1 | 2,7-naphthyridine derivative, preparation method therefor and use thereof |